Published in Anesthesiology on September 01, 2010
Epidural Anesthesia/Analgesia and Outcome of Patients After Lung Cancer Surgery | NCT02801409
Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery | NCT04025840
Standard perioperative management in gastrointestinal surgery. Langenbecks Arch Surg (2011) 1.03
Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine? Front Oncol (2015) 1.01
Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology (2011) 0.92
The effect of anesthetic technique on survival in human cancers: a meta-analysis of retrospective and prospective studies. PLoS One (2013) 0.91
Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses. Cancers (Basel) (2010) 0.88
Can anesthetic techniques or drugs affect cancer recurrence in patients undergoing cancer surgery? J Anesth (2013) 0.87
Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancer. PLoS One (2013) 0.85
Anesthetic techniques and cancer recurrence after surgery. ScientificWorldJournal (2014) 0.84
Can regional anesthesia and analgesia prolong cancer survival after orthopaedic oncologic surgery? Clin Orthop Relat Res (2014) 0.83
Perspectives in anaesthesia for cancer surgery. J Cancer Res Clin Oncol (2013) 0.82
Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study. Br J Anaesth (2013) 0.80
Comparison of combined general-epidural anesthesia with general anesthesia effects on survival and cancer recurrence: a meta-analysis of retrospective and prospective studies. PLoS One (2014) 0.80
Effectiveness of epidural versus alternate analgesia for pain relief after radical prostatectomy and correlation with biochemical recurrence in men with prostate cancer. Res Rep Urol (2013) 0.79
Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients. Ochsner J (2014) 0.79
The effect of neuraxial anesthesia on cancer recurrence and survival after cancer surgery: an updated meta-analysis. Oncotarget (2016) 0.77
Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study. Reg Anesth Pain Med (2014) 0.77
Anesthesia needs large international clinical trials. HSR Proc Intensive Care Cardiovasc Anesth (2010) 0.75
Dexmedetomidine Inhibits Maturation and Function of Human Cord Blood-Derived Dendritic Cells by Interfering with Synthesis and Secretion of IL-12 and IL-23. PLoS One (2016) 0.75
Anesthesia and cancer recurrence: What is the evidence? J Anaesthesiol Clin Pharmacol (2014) 0.75
Short and Long-Term Outcomes of Epidural or Intravenous Analgesia after Esophagectomy: A Propensity-Matched Cohort Study. PLoS One (2016) 0.75
Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst (2009) 3.83
Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol (2003) 3.58
Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur Urol (2011) 3.47
Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol (2011) 3.44
The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol (2007) 3.20
Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol (2008) 2.83
Twenty years experience with an ileal orthotopic low pressure bladder substitute--lessons to be learned. J Urol (2006) 2.82
Contemporary role of androgen deprivation therapy for prostate cancer. Eur Urol (2011) 2.68
Urinary diversion. Urology (2007) 2.65
Nerve sparing open radical retropubic prostatectomy--does it have an impact on urinary continence? J Urol (2006) 2.65
Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer. Sci Transl Med (2012) 2.64
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol (2009) 2.55
Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Eur Urol (2008) 2.46
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res (2010) 2.39
Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy. J Clin Oncol (2003) 2.33
Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer? Eur Urol (2006) 2.32
Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology (2014) 2.25
Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer. Eur J Cancer (2012) 2.15
Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol (2011) 2.14
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. Lancet Oncol (2012) 2.06
EAU guidelines on surgical treatment of urinary incontinence. Eur Urol (2012) 2.05
Complete continence after botulinum neurotoxin type A injections for refractory idiopathic detrusor overactivity incontinence: patient-reported outcome at 4 weeks. Eur Urol (2009) 2.04
Occlusion of seminal vesicles increases sexual activity in a mouse model. Eur Urol (2012) 2.03
Influence of epidural mixture and surgery on bladder function after open renal surgery: a randomized clinical trial. Anesthesiology (2013) 1.98
Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol (2012) 1.96
A prospective randomized trial comparing 2 lithotriptors for stone disintegration and induced renal trauma. J Urol (2003) 1.84
Metastases in normal-sized pelvic lymph nodes: detection with diffusion-weighted MR imaging. Radiology (2014) 1.78
Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol (2010) 1.76
Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment. Eur Urol (2008) 1.73
Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol (2002) 1.71
Long-term results of standard procedures in urology: the ileal neobladder. World J Urol (2006) 1.68
Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? Eur Urol (2007) 1.68
Is newer always better? A comparative study of 3 lithotriptor generations. J Urol (2005) 1.67
Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study? J Urol (2006) 1.65
Individualized seminal vesicle sparing cystoprostatectomy combined with ileal orthotopic bladder substitution achieves good functional results. J Urol (2010) 1.64
A prospective randomised trial comparing the modified HM3 with the MODULITH® SLX-F2 lithotripter. Eur Urol (2011) 1.61
Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol (2005) 1.61
The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer. Eur Urol (2010) 1.61
Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. Eur Urol (2008) 1.60
Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder? J Urol (2006) 1.59
Renal oxygenation changes during acute unilateral ureteral obstruction: assessment with blood oxygen level-dependent mr imaging--initial experience. Radiology (2008) 1.58
BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am J Pathol (2007) 1.58
Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol (2004) 1.56
Increased proximal urethral sensory threshold after radical pelvic surgery in women. Neurourol Urodyn (2007) 1.53
Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol (2012) 1.52
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol (2003) 1.50
Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J Urol (2002) 1.50
Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol (2002) 1.50
Long-term outcome of ileal conduit diversion. J Urol (2003) 1.50
The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J Urol (2007) 1.49
The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol (2009) 1.49
Extracapsular extension but not the tumour burden of lymph node metastases is an independent adverse risk factor in lymph node-positive bladder cancer. Histopathology (2011) 1.46
Benign prostatic obstruction and parkinson's disease--should transurethral resection of the prostate be avoided? J Urol (2009) 1.45
Is bilateral extended pelvic lymphadenectomy necessary for strictly unilateral invasive bladder cancer? J Urol (2012) 1.45